Sectors All Transactions Business Services Consumer Global Healthcare Industrials Specialty Chemicals Transaction Type All Types Corporate Finance Advisory Debt & Equity Financings Mergers & Acquisitions Restructurings Sponsor Related HAVE BEEN ACQUIRED BY A PORTFOLIO COMPANY OF Artisan Plastic Surgery and Artisan Beauté have been Acquired by Olympus Cosmetic Group TM Capital served as exclusive financial advisor to Artisan Plastic Surgery and Artisan Beauté, in its sale to Olympus Cosmetic Group Details HAS AGREED TO A STRATEGIC INVESTMENT FROM Precipart has Agreed to a Strategic Investment from KKR TM Capital served as a financial advisor to Precipart in connection with a pending strategic investment from KKR Details HAS DIVESTED Methode Electronics has Divested Dabir TM Capital served as exclusive financial advisor to Methode Electronicsin the sale of its Dabir Surfaces business unit to Agiliti Details HAS BEEN ACQUIRED BY InNeuroCo has been Acquired by Integer TM Capital served as exclusive financial advisor to InNeuroCo in its sale to Integer Holdings Corporation Details a portfolio company of has been acquired by Montgomery DME has been Acquired by Incline Equity Partners TM Capital served as exclusive financial advisor to Montgomery DME (“MDME”), a portfolio company of Monument MicroCap Partners, in its sale to Incline Equity Partners Details A PORTFOLIO COMPANY OF HAS BEEN ACQUIRED BY Holland Capital’s Quantib has been Acquired by RadNet TM Capital served as exclusive financial advisor to Quantib B.V., a portfolio company of Holland Capital, in connection with its sale to RadNet, Inc. Details has Received a Strategic Investment from CPAP.com has Received a Strategic Investment from Cathay Capital TM Capital served as exclusive financial advisor to CPAP.com in connection with a strategic investment from Cathay Capital Details HAS BEEN ACQUIRED BY Neoteryx has been Acquired by Trajan Group TM Capital served as exclusive financial advisor to Neoteryx, LLC in connection with its sale to Trajan Group Holdings Limited (Australian Stock Exchange: TRJ) Details Has Been Acquired By Empirical Bioscience has been Acquired by Fortis Life Sciences TM Capital, together with Pegasus Capital, served as a financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences Details A Portfolio Company Of Has Been Acquired By Cortec Group’s Canadian Hospital Specialties has been Acquired by Flexpoint Ford TM Capital served as a financial advisor to Canadian Hospital Specialties, a portfolio company of Cortec Group, in its sale to Flexpoint Ford Details Has Received An Investment From Empower Community Care Receives Investment from Northlane Capital Partners TM Capital served as exclusive financial advisor to Empower Community Care in connection with an investment from Northlane Capital Partners Details $65 Million series c equity capital CorVista Raises Equity Capital TM Capital advised CorVista Health, Inc. in raising $65 million of Series C equity capital to advance its artificial intelligence-based cardiovascular diagnostic technology Details Has Received A Growth Equity Investment From DCN Receives Growth Equity Investment from Martis Capital TM Capital served as financial advisor to DCN Dx in connection with a growth equity investment from Martis Capital Details Has Sold Its Medical Business To A Portfolio Company Of TDK Hutchinson Divests HTI Medical to Resonetics TM Capital served as exclusive financial advisor to Hutchinson Technology, Inc., a subsidiary of TDK Corporation, in the sale of its medical division to Resonetics Details A Portfolio Company Of Has Been Acquired By An Investment Vehicle Sub-Managed By UltiMed has been acquired by Levine Leichtman Capital Partners TM Capital served as exclusive financial advisor to UltiMed, Inc., a portfolio company of LDI, Ltd., in its sale to an investment vehicle sub-managed by Levine Leichtman Capital Partners Details Has Been Acquired By A Portfolio Company Of Metrigraphics Acquired by Cirtec Medical TM Capital served as exclusive financial advisor to Metrigraphics in its sale to Cirtec Medical, a portfolio company of 3i Group plc (LSE:III) Details Next Load More